Health By STAT staff Watch: Testing failures have plagued the U.S. response to Covid-19. How did we get here?
Health By Elizabeth Cooney 7 questions about Covid-19 testing and what it means for reopening the country
Politics By Lev Facher NIH announces $1.5 billion, ‘Shark Tank’-like initiative to accelerate Covid-19 testing
Biotech By Kate Sheridan For the first time, a blood test helped doctors find and treat multiple types of cancer in seemingly healthy people
First Opinion By Elliott J. Millenson Home testing for Covid-19 will provide the combination to unlock the U.S.
Exclusive By Matthew Herper Rapid coronavirus test, commonly used in U.S., may miss infections in some situations
Health By Erin Brodwin Scientists tap CRISPR’s search-and-detect skills to create a rapid Covid-19 test
Health Tech By Shafaq Zia ‘Smart toilet’ could monitor for signs of illness in urine and stool, study finds
First Opinion By Arjun K. Manrai and Kenneth D. Mandl Covid-19 testing: overcoming challenges in the next phase of the epidemic
Pharmalot By Ed Silverman Roche backpedals and agrees to provide a solution for Covid-19 tests in the Netherlands
Health By Andrew Joseph The next frontier in coronavirus testing: Identifying the full scope of the pandemic, not just individual infections
Health Tech By Erin Brodwin Startups touting at-home coronavirus tests suspend plans after FDA warning
First Opinion By Farzad Mostashari and Ezekiel J. Emanuel We need smart coronavirus testing, not just more testing
Pharmalot By Ed Silverman FDA moves to boost coronavirus testing capacity by giving states more power
Health By Lev Facher Trump administration says it will launch mobile coronavirus test system this week
Matt's Take By Matthew Herper Coronavirus testing is starting to get better — but it has a long way to go
Biotech By Rebecca Robbins Microbial signatures in the blood could offer new avenue for liquid biopsies to detect cancer
Health By Matthew Herper and Helen Branswell Shortage of crucial chemicals creates new obstacle to U.S. coronavirus testing
Biotech By Jonathan Saltzman — Boston Globe Thermo Fisher buys Dutch diagnostics company for $11.5 billion
Health Tech By Rebecca Robbins FDA names genes that may interact with specific drugs, offering clarity to genetic testing industry
